OpenURL Connection Search

Select item for more details and to access through your institution.

Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Published in:
2022
By:
- Lin, Wei-Yu;
- Fordham, Sarah E.;
- Hungate, Eric;
- Sunter, Nicola J.;
- Elstob, Claire;
- Xu, Yaobo;
- Park, Catherine;
- Quante, Anne;
- Strauch, Konstantin;
- Gieger, Christian;
- Skol, Andrew;
- Rahman, Thahira;
- Sucheston-Campbell, Lara;
- Wang, Junke;
- Hahn, Theresa;
- Clay-Gilmour, Alyssa I.;
- Jones, Gail L.;
- Marr, Helen J.;
- Jackson, Graham H.;
- Menne, Tobias
Publication type:
Correction Notice
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Published in:
Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26551-x
By:
- Lin, Wei-Yu;
- Fordham, Sarah E.;
- Hungate, Eric;
- Sunter, Nicola J.;
- Elstob, Claire;
- Xu, Yaobo;
- Park, Catherine;
- Quante, Anne;
- Strauch, Konstantin;
- Gieger, Christian;
- Skol, Andrew;
- Rahman, Thahira;
- Sucheston-Campbell, Lara;
- Wang, Junke;
- Hahn, Theresa;
- Clay-Gilmour, Alyssa I.;
- Jones, Gail L.;
- Marr, Helen J.;
- Jackson, Graham H.;
- Menne, Tobias
Publication type:
Article
A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: Recommendations for service development and implications for palliative care teams.
Published in:
Palliative Medicine, 2023, v. 37, n. 2, p. 215, doi. 10.1177/02692163221138880
By:
- Stenson, Charlotte L;
- Vidrine, Jennifer;
- Dewhurst, Felicity;
- Osborne, Wendy;
- Menne, Tobias;
- Stocker, Rachel
Publication type:
Article
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.
Published in:
British Journal of Haematology, 2024, v. 204, n. 1, p. 86, doi. 10.1111/bjh.19064
By:
- Walewska, Renata;
- Eyre, Toby A.;
- Barrington, Sally;
- Brady, Jessica;
- Fields, Paul;
- Iyengar, Sunil;
- Joshi, Anurag;
- Menne, Tobias;
- Parry‐Jones, Nilima;
- Walter, Harriet;
- Wotherspoon, Andrew;
- Linton, Kim
Publication type:
Article
A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience.
Published in:
British Journal of Haematology, 2022, v. 198, n. 3, p. 492, doi. 10.1111/bjh.18209
By:
- Kuhnl, Andrea;
- Roddie, Claire;
- Kirkwood, Amy A.;
- Tholouli, Eleni;
- Menne, Tobias;
- Patel, Amit;
- Besley, Caroline;
- Chaganti, Sridhar;
- Sanderson, Robin;
- O'Reilly, Maeve;
- Norman, Jane;
- Osborne, Wendy;
- Bloor, Adrian;
- Lugthart, Sanne;
- Malladi, Ram;
- Patten, Piers E. M.;
- Neill, Lorna;
- Martinez‐Cibrian, Nuria;
- Kennedy, Hannah;
- Phillips, Elizabeth H.
Publication type:
Article
Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline.
Published in:
British Journal of Haematology, 2021, v. 193, n. 4, p. 727, doi. 10.1111/bjh.17421
By:
- Shah, Nimish;
- Eyre, Toby A.;
- Tucker, David;
- Kassam, Shireen;
- Parmar, Jasvir;
- Featherstone, Carrie;
- Andrews, Peter;
- Asgari, Elham;
- Chaganti, Sridhar;
- Menne, Tobias F.;
- Fox, Christopher P.;
- Pettit, Stephen;
- Suddle, Abid;
- Bowles, Kristian M.
Publication type:
Article
Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)
Published in:
British Journal of Haematology, 2021, v. 193, n. 1, p. 63, doi. 10.1111/bjh.17073
By:
- Gibb, Adam;
- Pirrie, Sarah J.;
- Linton, Kim;
- Warbey, Victoria;
- Paterson, Kathryn;
- Davies, Andrew J.;
- Collins, Graham P.;
- Menne, Tobias;
- McKay, Pamela;
- Fields, Paul A.;
- Miall, Fiona M.;
- Nagy, Eszter;
- Wheatley, Keith;
- Reed, Rachel;
- Baricevic‐Jones, Ivona;
- Barrington, Sally;
- Radford, John
Publication type:
Article
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2014, v. 166, n. 1, p. 142, doi. 10.1111/bjh.12822
By:
- Jayakody Arachchillage, Deepa;
- Hurst, Erin;
- Carey, Peter;
- Moses, Samuel;
- O'Brien, Stephen G.;
- Menne, Tobias;
- Keenan, Fiona;
- Wallis, Jonathan P.
Publication type:
Article
The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast.
Published in:
Nature Genetics, 2007, v. 39, n. 4, p. 486, doi. 10.1038/ng1994
By:
- Menne, Tobias F.;
- Goyenechea, Beatriz;
- Sánchez-Puig, Nuria;
- Wong, Chi C.;
- Tonkin, Louise M.;
- Ancliff, Philip J.;
- Brost, Renée L.;
- Costanzo, Michael;
- Boone, Charles;
- Warren, Alan J.
Publication type:
Article
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
Published in:
American Journal of Hematology, 2023, v. 98, n. 5, p. 750, doi. 10.1002/ajh.26895
By:
- Arulogun, Suzanne O.;
- Brian, Duncan;
- Goradia, Harshita;
- Cooney, Aaron;
- Menne, Tobias;
- Koo, RayMun;
- O'Neill, Aideen T.;
- Vos, Josephine M. I.;
- Pratt, Guy;
- Turner, Deborah;
- Marshall, Kirsty;
- Manos, Kate;
- Anderson, Claire;
- Gavriatopoulou, Maria;
- Kyriakou, Charalampia;
- Kersten, Marie J.;
- Minnema, Monique C.;
- Koutoumanou, Eirini;
- El‐Sharkawi, Dima;
- Linton, Kim
Publication type:
Article
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
Published in:
Health Technology Assessment, 2021, v. 25, n. 47, p. vii, doi. 10.3310/hta25470
By:
- Wu, Olivia;
- McCartney, Elaine;
- Heggie, Robert;
- Germeni, Evi;
- Paul, James;
- Soulis, Eileen;
- Dillon, Susan;
- Ryan, Caoimhe;
- Sim, Moira;
- Dixon-Hughes, Judith;
- Agarwal, Roshan;
- Bodenham, Andrew;
- Menne, Tobias;
- Jones, Brian;
- Moss, Jonathan
Publication type:
Article
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 89, doi. 10.1016/j.clml.2021.08.005
By:
- Kwak, Larry W.;
- Sancho, Juan-Manuel;
- Seok-Goo Cho;
- Hideyuki Nakazawa;
- Junji Suzumiya;
- Gayane Tumyan;
- Jin Seok Kim;
- Menne, Tobias;
- Mariz, José;
- Ilyin, Nikolai;
- Jurczak, Wojciech;
- Martinez, Aurelio Lopez;
- Samoilova, Olga;
- Zhavrid, Edvard;
- Ruiz, Eduardo Yañez;
- Trneny, Marek;
- Popplewell, Leslie;
- Ogura, Michinori;
- Won-Seog Kim;
- Sang Joon Lee
Publication type:
Article
TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S411, doi. 10.1016/S2152-2650(21)01925-X
By:
- Iyer, Swaminathan;
- Trümper, Lorenz;
- O'Connor, Owen A.;
- Pro, Barbara;
- Illidge, Tim;
- Advani, Ranjana;
- Bartlett, Nancy L.;
- Christensen, Jacob Haaber;
- Morschhauser, Franck;
- Domingo-Domenech, Eva;
- Rossi, Giuseppe;
- Won Seog Kim;
- Feldman, Tatyana;
- Menne, Tobias;
- Belada, David;
- Illès, Árpád;
- Tobinai, Kensei;
- Kunihiro Tsukasaki;
- Su-Peng Yeh;
- Shustov, Andrei
Publication type:
Article
Poster: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S247, doi. 10.1016/S2152-2650(21)01557-3
By:
- Iyer, Swaminathan;
- Trümper, Lorenz;
- O'Connor, Owen A.;
- Pro, Barbara;
- Illidge, Tim;
- Advani, Ranjana;
- Bartlett, Nancy L.;
- Christensen, Jacob Haaber;
- Morschhauser, Franck;
- Domingo-Domenech, Eva;
- Rossi, Giuseppe;
- Kim, Won Seog;
- Feldman, Tatyana;
- Menne, Tobias;
- Belada, David;
- Illès, Árpád;
- Tobinai, Kensei;
- Tsukasaki, Kunihiro;
- Yeh, Su-Peng;
- Shustov, Andrei
Publication type:
Article
Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01276-3
By:
- Iyer, Swaminathan;
- Trümper, Lorenz;
- O'Connor, Owen A.;
- Pro, Barbara;
- Illidge, Tim;
- Advani, Ranjana;
- Bartlett, Nancy L.;
- Christensen, Jacob Haaber;
- Morschhauser, Franck;
- Domingo-Domenech, Eva;
- Rossi, Giuseppe;
- Won Seog Kim;
- Feldman, Tatyana;
- Menne, Tobias;
- Belada, David;
- Illès, Árpád;
- Tobinai, Kensei;
- Tsukasaki, Kunihiro;
- Su-Peng Yeh;
- Shustov, Andrei
Publication type:
Article
Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England.
Published in:
EJHaem, 2024, v. 5, n. 5, p. 992, doi. 10.1002/jha2.970
By:
- Fox, Christopher P.;
- Townsend, William;
- Gribben, John G.;
- Menne, Tobias;
- Kalakonda, Nagesh;
- Williams, Paula;
- Toron, Farah;
- Tyas, Emma;
- Cooper, Miranda;
- Rickards, Joshua;
- Radford, John
Publication type:
Article

Found: 16